Upregulation of Acetylcholinesterase Mediated by P53 Contributes to Cisplatin-Induced Apoptosis in Human Breast Cancer Cell

Journal of Cancer - Australia
doi 10.7150/jca.10521
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Regulation of PUMA-α by P53 in Cisplatin-Induced Renal Cell Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Dicoumarol Potentiates Cisplatin-Induced Apoptosis Mediated by C-Jun N-Terminal Kinase in P53 Wild-Type Urogenital Cancer Cell Lines

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Dynamin-Related Protein 1-Mediated Mitochondrial Fission Contributes to IR-783-induced Apoptosis in Human Breast Cancer Cells

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

MicroRNA-34a Is Induced via P53 During Cisplatin Nephrotoxicity and Contributes to Cell Survival

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2010English

EBF1-mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the P53 Signaling Pathway

Cancer Research
Cancer ResearchOncology
2019English

Caspase-Mediated Cleavage of ATM During Cisplatin-Induced Tubular Cell Apoptosis: Inactivation of Its Kinase Activity Toward P53

American Journal of Physiology - Renal Physiology
UrologyPhysiology
2006English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Ribozyme-Mediated Attenuation of Survivin Expression Sensitizes Human Melanoma Cells to Cisplatin-Induced Apoptosis

Journal of Clinical Investigation
Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy